- Home
- TETE vs OPTN Comparison
TETE vs OPTN Comparison
Compare TETE & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TETE
- OPTN
- Stock Information
- Founded
- TETE 2021
- OPTN 2010
- Country
- TETE Malaysia
- OPTN United States
- Employees
- TETE N/A
- OPTN N/A
- Industry
- TETE Blank Checks
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- TETE Finance
- OPTN Health Care
- Exchange
- TETE Nasdaq
- OPTN Nasdaq
- Market Cap
- TETE 73.0M
- OPTN 78.4M
- IPO Year
- TETE 2022
- OPTN 2017
- Fundamental
- Price
- TETE $12.28
- OPTN $6.38
- Analyst Decision
- TETE
- OPTN Strong Buy
- Analyst Count
- TETE 0
- OPTN 3
- Target Price
- TETE N/A
- OPTN $16.67
- AVG Volume (30 Days)
- TETE 1.9K
- OPTN 60.7K
- Earning Date
- TETE 01-01-0001
- OPTN 03-06-2025
- Dividend Yield
- TETE N/A
- OPTN N/A
- EPS Growth
- TETE N/A
- OPTN N/A
- EPS
- TETE 0.02
- OPTN N/A
- Revenue
- TETE N/A
- OPTN $75,672,000.00
- Revenue This Year
- TETE N/A
- OPTN $13.42
- Revenue Next Year
- TETE N/A
- OPTN $38.54
- P/E Ratio
- TETE $697.14
- OPTN N/A
- Revenue Growth
- TETE N/A
- OPTN 5.13
- 52 Week Low
- TETE $11.42
- OPTN $4.82
- 52 Week High
- TETE $12.45
- OPTN $31.50
- Technical
- Relative Strength Index (RSI)
- TETE 48.59
- OPTN 49.78
- Support Level
- TETE $12.03
- OPTN $5.16
- Resistance Level
- TETE $12.45
- OPTN $6.97
- Average True Range (ATR)
- TETE 0.03
- OPTN 0.66
- MACD
- TETE -0.02
- OPTN 0.10
- Stochastic Oscillator
- TETE 59.52
- OPTN 71.08
About TETE Technology & Telecommunication Acquisition Corporation
Technology & Telecommunication Acquisition Corp is a blank check company.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.